A detailed history of Daiwa Securities Group Inc. transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 314 shares of AVXL stock, worth $2,521. This represents 0.0% of its overall portfolio holdings.

Number of Shares
314
Previous 314 -0.0%
Holding current value
$2,521
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 06, 2023

BUY
$7.65 - $14.43 $703 - $1,327
92 Added 41.44%
314 $3,000
Q4 2021

Feb 03, 2022

BUY
$16.88 - $23.31 $3,747 - $5,174
222 New
222 $4,000

Others Institutions Holding AVXL

About ANAVEX LIFE SCIENCES CORP.


  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $626M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track Daiwa Securities Group Inc. Portfolio

Follow Daiwa Securities Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.